Skip to main content

Research Repository

Advanced Search

Professor JO LEONARDI-BEE's Outputs (10)

Barriers and facilitators to type 2 diabetes management in the Caribbean region: a qualitative systematic review (2020)
Journal Article
Nixon, A. L., Leonardi-Bee, J., Wang, H., & Chattopadhyay, K. (2021). Barriers and facilitators to type 2 diabetes management in the Caribbean region: a qualitative systematic review. JBI Evidence Synthesis, 19(5), 911-965. https://doi.org/10.11124/jbisrir-d-19-00424

Objective:The objective of this systematic review was to summarize the barriers and facilitators to type 2 diabetes mellitus management in the Caribbean region.Introduction:The prevalence of type 2 diabetes mellitus in the Caribbean is of significant... Read More about Barriers and facilitators to type 2 diabetes management in the Caribbean region: a qualitative systematic review.

Using Trial Sequential Analysis for estimating the sample sizes of further trials: example using smoking cessation intervention (2020)
Journal Article
Claire, R., Gluud, C., Berlin, I., Coleman, T., & Leonardi-Bee, J. (2020). Using Trial Sequential Analysis for estimating the sample sizes of further trials: example using smoking cessation intervention. BMC Medical Research Methodology, 20(1), Article 284. https://doi.org/10.1186/s12874-020-01169-7

Background: Assessing benefits and harms of health interventions is resource-intensive and often requires feasibility and pilot trials followed by adequately powered randomised clinical trials. Data from feasibility and pilot trials are used to infor... Read More about Using Trial Sequential Analysis for estimating the sample sizes of further trials: example using smoking cessation intervention.

Interventions for basal cell carcinoma of the skin (2020)
Journal Article
Thomson, J., Hogan, S., Leonardi-Bee, J., Williams, H. C., & Bath-Hextall, F. J. (2020). Interventions for basal cell carcinoma of the skin. Cochrane Library, 2020, Article CD003412. https://doi.org/10.1002/14651858.CD003412.pub3

Background: Basal cell carcinoma (BCC) is the commonest cancer affecting white-skinned individuals, and worldwide incidence is increasing. Although rarely fatal, BCC is associated with significant morbidity and costs. First-line treatment is usually... Read More about Interventions for basal cell carcinoma of the skin.

Quality of smoking cessation advice in guidelines of tobacco-related diseases: An updated systematic review (2020)
Journal Article
Ekezie, W., Murray, R. L., Agrawal, S., Bogdanovica, I., Britton, J., Leonardi-Bee, J., & Tobacco Advisory Group of the Royal College of Physicians. (2020). Quality of smoking cessation advice in guidelines of tobacco-related diseases: An updated systematic review. Clinical Medicine, 20(6), 551-559. https://doi.org/10.7861/clinmed.2020-0359

Tobacco smoking is a major risk factor for a wide range of diseases, and smoking cessation significantly reduces these risks. Clinical guidelines for diseases associated with smoking should therefore include guidance on smoking cessation. This review... Read More about Quality of smoking cessation advice in guidelines of tobacco-related diseases: An updated systematic review.

Acceptability of bisphosphonates among patients, clinicians and managers: a systematic review and framework synthesis. (2020)
Journal Article
Paskins, Z., Crawford-Manning, F., Cottrell, E., Corp, N., Wright, J., Jinks, C., Bishop, S., Doyle, A., Ong, T., Gittoes, N., Leonardi-Bee, J., Langley, T., Horne, R., & Sahota, O. (2020). Acceptability of bisphosphonates among patients, clinicians and managers: a systematic review and framework synthesis. BMJ Open, 10(11), Article e040634. https://doi.org/10.1136/bmjopen-2020-040634

OBJECTIVE: To explore the acceptability of different bisphosphonate regimens for the treatment of osteoporosis among patients, clinicians and managers, payers and academics.

DESIGN: A systematic review of primary qualitative studies. Seven databas... Read More about Acceptability of bisphosphonates among patients, clinicians and managers: a systematic review and framework synthesis..

Experiences and views of women, children, and professionals regarding second-hand smoke exposure prevention in Middle Eastern countries: a qualitative systematic review protocol (2020)
Journal Article
Hassanein, Z., Langley, T., Murray, R., Bogdanovica, I., & Leonardi-Bee, J. (2021). Experiences and views of women, children, and professionals regarding second-hand smoke exposure prevention in Middle Eastern countries: a qualitative systematic review protocol. JBI Evidence Synthesis, 18(1), 222-228. https://doi.org/10.11124/JBISRIR-D-19-00248

Objective: This systematic review aims to identify and explore the experiences and views regarding secondhand smoke (SHS) exposure among women and children in the home, workplace, school, personal vehicles, and public places from the perspectives of... Read More about Experiences and views of women, children, and professionals regarding second-hand smoke exposure prevention in Middle Eastern countries: a qualitative systematic review protocol.

Predicting major adverse cardiovascular events for secondary prevention: protocol for a systematic review and meta-analysis of risk prediction models (2020)
Journal Article
Akyea, R. K., Leonardi-Bee, J., Asselbergs, F. W., Patel, R. S., Durrington, P., Wierzbicki, A. S., Ibiwoye, O. H., Kai, J., Qureshi, N., & Weng, S. F. (2020). Predicting major adverse cardiovascular events for secondary prevention: protocol for a systematic review and meta-analysis of risk prediction models. BMJ Open, 10(7), Article e034564. https://doi.org/10.1136/bmjopen-2019-034564

Introduction: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality globally. With advances in early diagnosis and treatment of CVD and increasing life expectancy, more people are surviving initial CVD events. However, models t... Read More about Predicting major adverse cardiovascular events for secondary prevention: protocol for a systematic review and meta-analysis of risk prediction models.

Effectiveness and safety of Ayurvedic medicines in type-2 diabetes management: a systematic review protocol (2020)
Journal Article
Chattopadhyay, K., Panniyammakal, J., Biswas, T. K., Heinrich, M., Lewis, S. A., Greenfield, S. M., Tandon, N., Kinra, S., & Leonardi-Bee, J. (2020). Effectiveness and safety of Ayurvedic medicines in type-2 diabetes management: a systematic review protocol. JBI Evidence Synthesis, 18(11), 2380-2389. https://doi.org/10.11124/JBISRIR-D-19-00350

Objective: To evaluate and synthesize evidence on the effectiveness and safety of Ayurvedic medicines for managing type-2 diabetes (T2DM).

Introduction: Several randomized controlled trials (RCTs) have been conducted to assess the effectiveness an... Read More about Effectiveness and safety of Ayurvedic medicines in type-2 diabetes management: a systematic review protocol.

Guidance for the Conduct and Reporting of Clinical Trials of Breast Milk Substitutes (2020)
Journal Article
Jarrold, K., Helfer, B., Eskander, M., Crawley, H., Trabulsi, J., Caulfield, L. E., Duffy, G., Garcia-Larsen, V., Hayward, D., Hyde, M., Jeffries, S., Knip, M., Leonardi-Bee, J., Loder, E., Lodge, C. J., Lowe, A. J., McGuire, W., Osborn, D., Przyrembel, H., Renfrew, M. J., …Boyle, R. J. (2020). Guidance for the Conduct and Reporting of Clinical Trials of Breast Milk Substitutes. JAMA Pediatrics, 174(9), 874-881. https://doi.org/10.1001/jamapediatrics.2020.0578

Importance: Breast milk substitutes (BMS) are important nutritional products evaluated in clinical trials. Concerns have been raised about the risk of bias in BMS trials, the reliability of claims that arise from such trials, and the potential for B... Read More about Guidance for the Conduct and Reporting of Clinical Trials of Breast Milk Substitutes.